Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Center, Randomized Controlled Prospective Double-blinded Trial Comparing Haloperidol to Standard Ondansetron Therapy for Control of Nausea and Vomiting in the Emergency Department

NCT04764344 is registered in ClinicalTrials.gov with Western Michigan University School of Medicine as lead sponsor.

NCT NCT04764344
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04764344 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Center, Randomized Controlled Prospective Double-blinded Trial Comparing Haloperidol to Standard Ondansetron Therapy for Control of Nausea and Vomiting in the Emergency Department
Lead sponsor
Western Michigan University School of Medicine
Phase
Phase 4
Overall status
Completed
Start date
April 1, 2021
Completion date
May 22, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abdominal pain, cannabis use, nausea, vomiting